Tesla Inc (NASDAQ:TSLA) shares surged more than 5.5% on Friday as investors welcomed signs of a possible détente between CEO Elon Musk and President Donald Trump following a volatile day of public sparring that had raised concerns over future regulatory risks.
Wedbush analyst Dan Ives acknowledged the drama surrounding the pair’s recent falling-out, calling it “one of the strangest Twilight Zone days we have seen” in years of covering Musk, but stressed the market reaction had gone too far.
Silver prices continued to make gains on Friday, trading above $36 per ounce, their highest level in more than 13 years.
Prices have increased approximately 24.3% since the start of the year, supported by a persistent supply deficit and increasing demand from both investors and industrial users.
Docusign (NASDAQ:DOCU) shares plunged more than 17% in early trade on Friday as the electronic document signing company reported mixed earnings for the fiscal first quarter.
A billings miss and lower fiscal 2026 billings guidance overshadowed beats on the top and bottom lines.
HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) announced a 58% increase in peak Bitcoin mining hashrate for May 2025, rising from 6.6 EH/s in April to 10.4 EH/s, as the company continues to scale operations and expand capacity.
The company attributed this growth to the successful energization of HIVE’s 100 MW hydro-powered facility in Paraguay, contributing to its global network powered entirely by hydroelectric energy.
Shares in Manchester United Plc (NYSE:MANU) traded higher on Friday as the struggling football giant told investors that it ‘remains in compliance’ with the Premier League’s Profit and Sustainability Rules (PSR).
United said it was also in compliance with UEFA’s Financial Fair Play Regulations.
Candel Therapeutics Inc (NASDAQ:CADL) has appointed biotechnology industry veteran Maha Radhakrishnan, M.D., to its board of directors.
Dr Radhakrishnan brings more than two decades of experience in drug development and commercialization across multiple therapeutic areas.
Shares of TNR Gold Corp (TSX-V:TNR, OTC:TRRXF) are set to end the week on a high after the royalty company's stock spiked on Thursday, climbing as much as 33% to an intraday high of $0.08 and continued to add another 13% on Friday.
Trading volume spiked to 3.7 million shares—well above average—as investors responded to growing market interest in the company's strategic review and prized royalty assets.
Shares in ValiRx fell 10% after the biotech firm published its 2024 results, highlighting a continued loss and a warning over its future funding needs.
The drug development micro-cap reported a total loss of £1.92 million for the year, slightly lower than the previous year, and a loss per share of 1.45p.
Shares in Pinewood Technologies Group, the automotive intelligence group, jumped 17% in early trading after the company announced a $76.5 million deal to acquire full control of its North American joint venture with Lithia Motors. T
The acquisition, to be settled through new share issuance, gives Pinewood.AI complete ownership of Pinewood North America LLC and removes a key obstacle to broader market adoption in the US and Canada.